Someone struggling with constant hunger and food noise may need a different strategy from someone concerned about visceral abdominal fat, reduced muscle mass, poor sleep, low energy, or a weight-loss plateau
Regarding mortality, a total of 16 deaths were reported in semaglutide treatment groups, 8 deaths were reported in active comparator groups (empagliflozin, sitagliptin, liraglutide, and dulaglutide), and 3 deaths were reported in placebo groups
The schedule moves from 0.25 mg weekly to 0.5 mg, then 1.0 mg, 1.7 mg, and finally 2.4 mg, with each step lasting four weeks [6]
Ensure this is document in current record too